跳至主要内容
临床试验/JPRN-jRCT1080220913
JPRN-jRCT1080220913未知Unknown

A prospective observational study of the efficacy and safety of CPT-11 based regimens for UGT1A1 genotype guided patients with metastatic colorectal cancer

DAIICHI SANKYO COMPANY, LIMITED0 个研究点目标入组 2,000 人开始时间: 2009年11月10日最近更新:
适应症

试验速览

阶段
Unknown
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1. Metastatic colorectal cancer (adenocarcinoma)
  • 2. Patients to receiving FOLFIRI, CPT-11+S-1 and CPT-11 alone therapy (with or without molecular targeted agents)
  • Age requirement none

排除标准

  • 1. Contraindications of CPT-11
  • 2. ECOG PS 3-4
  • 3. Patients to receiving CPT-11 as adjuvant chemotherapy
  • 4. History of a pelvic irradiation

研究者

相似试验